查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1530007

心臟定位设备市场规模、份额、趋势分析报告：按类型、按适应症、按最终用途、按地区、细分市场预测，2024-2030 年

Cardiac Mapping Devices Market Size, Share & Trends Analysis Report, By Type, By Indication, By End Use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

心臟定位设备市场成长与趋势：

根据Grand View Research, Inc的最新报告，预计2030年全球心臟定位设备市场规模将达36.9亿美元，2024年至2030年复合年增长率为9.1%。

促进市场扩张的主要因素包括心律不整病例和心血管手术患者数量的增加、老年人口的增加、心臟定位系统的技术进步以及政府的支持措施。根据心律协会 2023 年 8 月发表的一篇论文，心房颤动 (AFib) 是最常见的心律不整类型，影响全球约 4000 万人，其中美国有 600 万人。

40 岁以上的成年人中，大约四分之一有心房颤动的风险，但许多人不知道其症状、可用的治疗方法以及早期疗育以防止进展的重要性。心臟定位系统的进步也将推动市场成长。例如，2024 年 6 月，将引入新的映射技术，例如在心外膜上绘製心臟动脉和静脉的多电极篮和导管，使得真空治疗期间的3D活化序列成为可能。电脑化非接触式测绘使用数学演算法重建电图并创建3D电位图，而无需直接接触心内膜。

心臟电生理学远端监测和感染预防方面的进步使得在临床环境之外持续监测患者的心率成为可能，从而可以快速调整治疗并降低侵入性手术造成的感染风险。此外，主要企业的多项策略措施正在推动市场成长。例如，强生公司的 BioSense Webster 于 2024 年 7 月推出了 Optrell，这是一种采用 TrueRef 技术的标测导管。 Optrell 由加州欧文市的 Biosense Webster 设计，是一种与 Carto 3 系统整合的高密度诊断导管。小电极放置在固定阵列中，以提供复杂心律不整的精确电生理学定位。

心臟定位设备市场报告亮点

  • 由于技术进步、主要企业的策略性倡议以及心血管手术量的增加，接触式心臟定位系统领域在 2023 年占据最大份额，超过 57.07%。
  • 由于心律不整病例增加及老年人口增加，2023年心房颤动细分市场占比最大，超过45.87%。
  • 2023年，医院板块占比最大，为69.38%。医院在采用和评估先进心臟定位设备等新技术方面发挥着重要作用。这些设备使医院能够为心律不整患者提供最先进的治疗，确保更好的结果并推动电生理学领域的发展。
  • 由于包括心律不整在内的心血管疾病（CVD）患者数量不断增加，2023年北美占全球市场的41.39%。产品发布、监管核准和先进的医疗基础设施。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章全球心臟定位设备市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 心臟定位设备市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章心臟定位设备市场：类型估计与趋势分析

  • 心臟定位设备市场：模式仪表板
  • 心臟定位设备市场：类型变化分析
  • 2018-2030 年心臟定位设备市场规模、预测与趋势分析（按类型）
  • 关于心臟定位系统的询问
  • 非接触式心臟定位系统

第五章心臟定位设备市场：适应症估计与趋势分析

  • 心臟定位设备市场：自适应仪表板
  • 心臟定位设备市场：自适应变异分析
  • 2018-2030 年心臟定位设备市场规模、预测与趋势分析（依适应症）
  • 心房颤动
  • 心房扑动
  • 其他的

第六章心臟定位设备市场：最终用途估计与趋势分析

  • 心臟定位设备市场：最终用途仪表板
  • 心臟定位设备市场：最终用途变化分析
  • 2018-2030 年心臟定位设备市场规模、预测与趋势分析（依最终用途）
  • 医院
  • 诊断中心
  • 其他的

第七章心臟定位设备市场：按国家、类型、最终用途和最终用途进行的区域估计和趋势分析

  • 全球心臟定位设备市场：区域仪表板
  • 2018-2030年市场规模及预测趋势分析
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第八章 竞争格局

  • 主要製造商的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
    • List of key distributors and channel partners
    • Key customers
    • Key company market share analysis, 2023
    • Abbott
    • Medtronic
    • BIOTRONIK
    • Acutus Medical
    • APN Health, LLC
    • Johnson &Johnson
    • Biosig Technologies, Inc.
    • Boston Scientific Corporation
    • Kardium, Inc.
    • Koninklijke Philips NV
    • Microport Scientific Corporation
Product Code: GVR-4-68040-381-1

Cardiac Mapping Devices Market Growth & Trends:

The global cardiac mapping devices market size is expected to reach USD 3.69 billion by 2030, registering a CAGR of 9.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. The primary factors driving the market expansion include the rising arrhythmia cases & number of cardiac surgery patients, growing geriatric population, technological advancements in cardiac mapping systems, and supportive government initiatives. According to the Heart Rhythm Society article published in August 2023, Atrial fibrillation (AFib), the most common type of cardiac arrhythmia, affects nearly 40 million people worldwide, including 6 million in the U.S. Its widespread prevalence underscores the need for advanced diagnostic and treatment options.

Approximately 1 in 4 adults over 40 are at risk of developing AFib, yet many are unaware of its symptoms, available treatments, and the importance of early intervention to prevent progression. Advancements in cardiac mapping systems also drive market growth. For instance, in June 2024, new mapping techniques, such as multielectrode baskets and catheters mapping across cardiac arteries and veins on the epicardium, enabled three-dimensional activation sequence definition during vacuum therapy. Computerized non-contact mapping uses mathematical algorithms to reconstruct electrograms and generate three-dimensional isopotential maps without direct heart endocardium contact.

Advances in remote monitoring and infection prevention in cardiac electrophysiology support continuous patient heart rhythm monitoring outside clinical settings, allowing prompt treatment adjustments and reducing invasive procedure infection risks. Moreover, several strategic initiatives by key players fuel the market's growth. For instance, in July 2024, Johnson & Johnson's Biosense Webster launched the Optrell mapping catheter, incorporating TrueRef technology. Designed in Irvine, California, by Biosense Webster, Optrell is a high-density diagnostic catheter that integrates with the Carto 3 system. It utilizes small electrodes in a fixed array configuration to provide accurate electrophysiological mapping for complex cardiac arrhythmias.

Cardiac Mapping Devices Market Report Highlights:

  • The contact cardiac mapping systems segment held the largest share of over 57.07%, in 2023 due to technological advancements, strategic initiatives by key players, and a rising volume of cardiac procedures
  • The atrial fibrillation segment held the largest share of over 45.87% in 2023 due to increased cases of arrhythmia and high geriatric population
  • The hospitals segment held the largest share of 69.38% in 2023. Hospitals play a vital role in adopting and assessing new technologies, such as advanced cardiac mapping devices. These devices enable hospitals to deliver state-of-the-art care for patients with cardiac arrhythmias, ensuring better outcomes and advancing the field of electrophysiology
  • North America dominated the global market with a share of 41.39% in 2023 owing to the increased cases of cardiovascular diseases (CVDs), including arrhythmias. Product launches, regulatory approvals, and advanced healthcare infrastructure

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Indication
    • 1.2.3. End-use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecast timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity price analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type Segment
    • 2.2.2. Indication Segment
    • 2.2.3. End-use Segment
    • 2.2.4. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Cardiac Mapping Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing number of cardiac surgery patients
      • 3.2.1.2. Rising arrhythmia cases
      • 3.2.1.3. Technological advancements in mapping systems
      • 3.2.1.4. Growing number of cardiovascular diseases (CVD)
      • 3.2.1.5. Rising geriatric population
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of cardiac mapping systems
      • 3.2.2.2. Lack of adequate infrastructure
  • 3.3. Cardiac Mapping Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Cardiac Mapping Devices Market: Type Estimates & Trend Analysis

  • 4.1. Cardiac Mapping Devices Market: Type Dashboard
  • 4.2. Cardiac Mapping Devices Market: Type Movement Analysis
  • 4.3. Cardiac Mapping Devices Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Contact cardiac mapping systems
    • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5. Non-contact cardiac mapping systems
    • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Cardiac Mapping Devices Market: Indication Estimates & Trend Analysis

  • 5.1. Cardiac Mapping Devices Market: Indication Dashboard
  • 5.2. Cardiac Mapping Devices Market: Indication Movement Analysis
  • 5.3. Cardiac Mapping Devices Market Size & Forecasts and Trend Analysis, by Indication, 2018 to 2030 (USD Million)
  • 5.4. Atrial Fibrillation
    • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5. Atrial Flutter
    • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Cardiac Mapping Devices Market: End Use Estimates & Trend Analysis

  • 6.1. Cardiac Mapping Devices Market: End Use Dashboard
  • 6.2. Cardiac Mapping Devices Market: End Use Movement Analysis
  • 6.3. Cardiac Mapping Devices Market Size & Forecasts and Trend Analysis, by End-use, 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5. Diagnostic Centers
    • 6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Cardiac Mapping Devices Market: Regional Estimates & Trend Analysis by Country, Type, End-use, & End Use

  • 7.1. Global Cardiac Mapping Devices Market: Regional Dashboard
  • 7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
  • 7.3. North America
    • 7.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key country dynamics
      • 7.3.4.2. Regulatory framework/ reimbursement structure
      • 7.3.4.3. Competitive scenario
      • 7.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.8. Norway
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.9. Denmark
      • 7.4.9.1. Key country dynamics
      • 7.4.9.2. Regulatory framework/reimbursement structure
      • 7.4.9.3. Competitive scenario
      • 7.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.3. Japan
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.5. Australia
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.7. South Korea
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework/ reimbursement structure
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.3. South Africa
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework/ reimbursement structure
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. Abbott
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Medtronic
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. BIOTRONIK
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Acutus Medical
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. APN Health, LLC
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Johnson & Johnson
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Biosig Technologies, Inc.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Boston Scientific Corporation
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Kardium, Inc.
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Koninklijke Philips N.V
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. Microport Scientific Corporation
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Product benchmarking
      • 8.3.14.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 Global cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 4 Global cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 5 Global cardiac mapping devices market, by end-use, 2018 - 2030
  • Table 6 Global cardiac mapping devices market, by region, 2018 - 2030 (USD Million)
  • Table 7 North America cardiac mapping devices market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 9 North America cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 10 North America cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 11 U.S. cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 12 U.S. cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 13 U.S. cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 Canada cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 15 Canada cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 16 Canada cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 17 Mexico cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 18 Mexico cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 19 Mexico cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Europe cardiac mapping devices market, by country, 2018 - 2030 (USD Million)
  • Table 21 Europe cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 22 Europe cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 23 Europe cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 UK cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 25 UK cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 26 UK cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 27 Germany cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 28 Germany cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 29 Germany cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 30 France cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 31 France cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 32 France cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 Italy cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 34 Italy cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 35 Italy cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 36 Spain cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 37 Spain cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 38 Spain cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 Denmark cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 40 Denmark cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 41 Denmark cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 42 Sweden cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 43 Sweden cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 44 Sweden cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 Norway cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 46 Norway cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 47 Norway cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific cardiac mapping devices market, by Country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 52 Japan cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 53 Japan cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 54 Japan cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 China cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 56 China cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 57 China cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 58 India cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 59 India cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 60 India cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Australia cardiac mapping devices market, by country, 2018 - 2030 (USD Million)
  • Table 62 Australia cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 63 Australia cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 64 Australia cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 65 Thailand cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 67 Thailand cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 68 Thailand cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 South Korea cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 70 South Korea cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 71 South Korea cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 72 Latin America cardiac mapping devices market, by country, 2018 - 2030 (USD Million)
  • Table 73 Latin America cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 74 Latin America cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 75 Latin America cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 76 Brazil cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 77 Brazil cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 78 Brazil cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 79 Argentina cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 80 Argentina cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 81 Argentina cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 MEA cardiac mapping devices market, by country, 2018 - 2030 (USD Million)
  • Table 83 MEA cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 84 MEA cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 85 MEA cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 86 South Africa cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 87 South Africa cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 88 South Africa cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 90 Saudi Arabia cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 91 Saudi Arabia cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 92 UAE cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 93 UAE cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 94 UAE cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 95 Kuwait cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 96 Kuwait cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 97 Kuwait cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 98 Participant's overview
  • Table 99 Financial performance
  • Table 100 Key companies undergoing expansions
  • Table 101 Key companies undergoing acquisitions
  • Table 102 Key companies undergoing collaborations
  • Table 103 Key companies launching new types/services
  • Table 104 Key companies undergoing partnerships
  • Table 105 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Cardiac mapping devices market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Cardiac mapping devices market revenues, 2023, (USD Millions)
  • Fig. 9 Market driver relevance analysis (Current & future impact)
  • Fig. 10 Market restraint relevance analysis (Current & future impact)
  • Fig. 11 Porter's five forces analysis
  • Fig. 12 PESTLE analysis
  • Fig. 13 Cardiac mapping devices market type outlook:
  • Fig. 14 Cardiac mapping devices market: type movement analysis
  • Fig. 15 Segment dashboard
  • Fig. 16 Global contact cardiac mapping systems market, 2018 - 2030 (USD Million)
  • Fig. 17 Global non-contact cardiac mapping systems market, 2018 - 2030 (USD Million)
  • Fig. 18 Cardiac mapping devices market indication outlook:
  • Fig. 19 Cardiac mapping devices market: indication movement analysis
  • Fig. 20 Global atrial fibrillation market, 2018 - 2030 (USD Million)
  • Fig. 21 Global atrial flutter market, 2018 - 2030 (USD Million)
  • Fig. 22 Global others market, 2018 - 2030 (USD Million)
  • Fig. 23 Cardiac mapping devices market end-use outlook:
  • Fig. 24 Cardiac mapping devices market: end-use movement analysis
  • Fig. 25 Global hospitals market, 2018 - 2030 (USD Million)
  • Fig. 26 Global diagnostic centers market, 2018 - 2030 (USD Million)
  • Fig. 27 Global others market, 2018 - 2030 (USD Million)
  • Fig. 28 Regional market place: Key takeaways
  • Fig. 29 North America cardiac mapping devices market, 2018 - 2030 (USD Million)
  • Fig. 30 U.S. cardiac mapping devices market, 2018 - 2030 (USD Million)
  • Fig. 31 Canada cardiac mapping devices market, 2018 - 2030 (USD Million)
  • Fig. 32 Mexico cardiac mapping devices market, 2018 - 2030 (USD Million)
  • Fig. 33 Europe cardiac mapping devices market, 2018 - 2030 (USD Million)
  • Fig. 34 Germany cardiac mapping devices market, 2018 - 2030 (USD Million)
  • Fig. 35 UK cardiac mapping devices market, 2018 - 2030 (USD Million)
  • Fig. 36 France cardiac mapping devices market, 2018 - 2030 (USD Million)
  • Fig. 37 Italy cardiac mapping devices market, 2018 - 2030 (USD Million)
  • Fig. 38 Spain cardiac mapping devices market, 2018 - 2030 (USD Million)
  • Fig. 39 Asia Pacific cardiac mapping devices market, 2018 - 2030 (USD Million)
  • Fig. 40 Japan cardiac mapping devices market, 2018 - 2030 (USD Million)
  • Fig. 41 China cardiac mapping devices market, 2018 - 2030 (USD Million)
  • Fig. 42 India cardiac mapping devices market, 2018 - 2030 (USD Million)
  • Fig. 43 Australia cardiac mapping devices market, 2018 - 2030 (USD Million)
  • Fig. 44 Latin America cardiac mapping devices market, 2018 - 2030 (USD Million)
  • Fig. 45 Brazil cardiac mapping devices market, 2018 - 2030 (USD Million)
  • Fig. 46 MEA cardiac mapping devices market, 2018 - 2030 (USD Million)
  • Fig. 47 South Africa cardiac mapping devices market, 2018 - 2030 (USD Million)
  • Fig. 48 Saudi Arabia cardiac mapping devices market, 2018 - 2030 (USD Million)
  • Fig. 49 Market Participant Categorization
  • Fig. 50 Strategy mapping